ad image

Chimeric antigen receptor (CAR)

1 / 1
Anixa Biosciences
Phase I Trial

Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center

Anixa Biosciences

PR-M03-22-17Mar 30, 2022
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
Innovation

Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M07-17-NI-007Jul 07, 2017
Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy
Biologics

Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy

Emilie Branch

Pharma's Almanac

MCP-M06-17-NI-001Jun 08, 2017
1 / 1